Register for our free email digests:
Brenda Sandburg
Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.
Latest From Brenda Sandburg
US Federal Courts Can Operate Until Jan. 25; Patent Office Faces Eminent Closure Under Shutdown
Bristol-Celgene: Congressional Reps Want Assurance Merger Will Not Increase Prices
Reps. Welch and Rooney urge FTC and DOJ to condition their approval of the merger on inclusion of a pricing provision.
Co-Pay Vouchers May Not Be Enough To Boost Patient Adherence To Blood Thinners
Acute MI patients who received voucher had 3.3% increase in persistence with clopidogrel or ticagrelor, but no significant reduction in major adverse cardiovascular events, ARTEMIS study finds.
Dartmouth Researchers Call For FDA To Expand Regulation Of Rx Drug Marketing
In JAMA report, researchers document the evolution of drug advertising, suggest FDA monitor detailing and establish standards for disease awareness campaigns.
US FDA Advertising Citations Remain Rare In 2018
With only seven letters last year, Office of Prescription Drug Promotion appears to be continuing its enforcement retrenchment as agency reconsiders its approach to Rx communications.
US High Court Won’t Hear FCA, Patent Cases
The US Supreme Court announced Monday that it won’t hear a much-watched case that could have limited the government’s ability to bring False Claims Act cases if it knew of the alleged misconduct. Two drug-world patent cases were also declined.